International Journal of Clinical Medicine · 2015 · 49 citations · 23 references
Life SciencesImmunologyPharmacotherapyAutoimmunityImmunopathologyRheumatologyAutoimmune DiseasesCytokine-mediated PathologyImmune-mediated Inflammatory DiseasesInflammatory ArthritisInflammatory ProcessesJoint DiseaseAdult-onset Still DiseaseCytokine Receptor AntagonistsInflammatory Joint DisordersInterleukin-1 InhibitorsInterleukin-6 InhibitorsRheumatologic Corticosteroid Therapy
The adult onset Still’s disease is a rare affection characterised by occurrence of fever, arthralgia or arthritis and evanescent cutaneous eruption. Multiple other systemic lesions make the diagnosis more difficult. Several diagnostic criteria were formulated to confirm this disease. The physiopathology of the adult onset Still’s disease is not well elucidated. However, several studies based on new facts in physiopathology, improved the therapy of refractory forms for which the biotherapy was an interesting alternative. The TNF alpha receptor antagonists are efficient on systemic and articular manifestations of this disease and allow a corticosteroid’s saving. Tocilizumab (interleukin 6 receptor antagonist), and Anakinra (interleukin 1 receptor antagonist) are also new promising treatments for resistant forms.
23
E. G. L. Bywaters · Annals of the Rheumatic Diseases · 1971 · 764 citations · Full text
J. Pouchot, John S. Sampalis, F Beaudet et al. · Medicine · 1991 · 577 citations
Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease
Bruno Fautrel, E. Zing, Jean‐Louis Golmard et al. · Medicine · 2002 · 503 citations
Thierry Lequerré, Pierre Quartier, David Rosellini et al. · Annals of the Rheumatic Diseases · 2007 · 404 citations · Full text